Novocure's device shown to slow cancer progression in the brain in trial

Go back to Novocure's device shown to slow cancer progression in the brain in trial
(NASDAQ: NVCR) Delayed: 14.28 --0 (-0%)
Previous Close $14.28    52 Week High $28.95 
Open $14.28    52 Week Low $5.95 
Day High $14.28    P/E N/A 
Day Low $14.28    EPS $0.00 
Volume 1,244